MedPath

Chair-based and Standard Exercise Programs in People With COPD

Not Applicable
Recruiting
Conditions
Pulmonary Rehabilitation
COPD
Exercise
Interventions
Other: Standard Exercise Program
Other: Chair-based Exercise Program
Registration Number
NCT06201299
Lead Sponsor
Istanbul Medipol University Hospital
Brief Summary

Patients who are diagnosed with COPD by a pulmonology specialist and referred to pulmonary rehabilitation will be included in the study. Cases that meet the inclusion criteria will be randomized and divided into two groups, standard exercise program group (SGr) and chair-based exercise. program group will be called (ChGr). While standard exercises will be given to SGr, chair-based exercises will be applied to ChGr. All evaluation and initial training sessions of the cases will be held in the hospital. Apart from this, they will be asked to do their exercises at home with the exercise videos that will be sent to them. In order to ensure that home exercises are performed completely and correctly, 2 sessions of online simultaneous exercise training will be provided with a physiotherapist via videoconference on a smartphone, and exercise follow-ups will be carried out by calling once a week. The program duration is 8 weeks, 5 days a week.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
64
Inclusion Criteria
  • Being between the ages of 18-75 years
  • Having a diagnosis of COPD diagnosed according to clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS).
  • Presence of dyspnea on exertion
  • Stable clinical status at inclusion without infection or exacerbation in the previous 4 weeks *Having smart phone usage skills
Exclusion Criteria
  • Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\min).
  • A history of exertional syncope or the presence of any comorbidities (such as severe orthopedic or neurological deficits or unstable heart disease) that preclude exercise training.
  • Having participated in a pulmonary rehabilitation program within the last 12 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Standard Exercise GroupStandard Exercise ProgramExercises will be performed using theraband.
Chair-based Exercise GroupChair-based Exercise ProgramExercises will be performed with chair support.
Primary Outcome Measures
NameTimeMethod
Exercise capacity assesmentChange from baseline at 2 months

The 6-minute walking test will conduct in a 30-meter corridor in line with American Thoracic Society (ATS) guidelines. Participants will ask to walk as far as they can. Prior to and following the test, oxygen saturation, heart rate and Borg fatigue rating will measure, and the walking distance will record.

Secondary Outcome Measures
NameTimeMethod
Dyspnea evaluationChange from baseline at 2 months

Modified Medical Council Dyspnea score will rate the sensation of dyspnea as the person perceives it.The severity of dyspnea is rated on a scale of 0 to 4."0 point" means no dyspnea perception and "4point" means severe dyspnea perception.

Peripheral muscle strength measurementChange from baseline at 2 months

Strength measurements of major peripheral muscle groups will be made with a digital myometer.

Pulmonary function tests (PFTs)Change from baseline at 2 months

PFTs will perform by using the Pony Fx spirometry device, and according to the American Thoracic Society (ATS) guidelines

Psychological status assessmentChange from baseline at 2 months

Hospital Anxiety Depression scale:The levels of anxiety and depression will asses by Hospital Anxiety Depression Scale (HADS) .The HADS is a self-report rating scale of 14 items on a 4-point Likert scale (range 0-3). It is designed to measure anxiety and depression (7 items for each subscale). The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21).Several studies suggest a cut-off score of ≥8 to be optimal for best sensitivity and specificity. The HADS has sensitivity and specificity of about 80%, and a predictive validity for identification of about 70%.

Evaluation of fatigueChange from baseline at 2 months

The fatigue severity scale: A 9-item questionnaire with questions related to how fatigue interferes with certain activities and rates its severity.

The items are scored on a 7 point scale with 1 = strongly disagree and 7= strongly agree The minimum score = 9 and maximum score possible = 63. Higher the score = greater fatigue severity Another way of scoring: mean of all the scores with minimum score being 1 and maximum score being 7 Self-report scale

Respiratory muscle strength measurementChange from baseline at 2 months

The mouth pressure measurement (maximum inspiratory and expiratory pressure) will perform with the Pony Fx spirometry device. Patient will place a rubber mouthpiece with flanges, on the device, exhale/inhale slowly and completely, and then will try to breath in as hard as possible. The patient will allow to rest for about a minute and the maneuver will repeat. The aim is that the variability between measurements is less than 10 cm H2O. The maximum value will obtain.

Evaluation of quality of lifeChange from baseline at 2 months

Saint George Respiratory Questionaire (SGRQ) score: The SGRQ ranges from 0 (no impairment of quality of life) to 100 (highest impairment of quality of life).

Physical activity level assesmentChange from baseline at 2 months

The International Physical Activity Questionnaire (IPAQ) was developed as an instrument for cross-national monitoring of physical activity and inactivity. This measure assesses the types of intensity of physical activity and sitting time that people do as part of daily lives are considered to estimate total physical activity in MET-min/week and time spent sitting.

Trial Locations

Locations (1)

Yedikule Chest Disease Hospital

🇹🇷

Istanbul, Zeytinburnu, Turkey

© Copyright 2025. All Rights Reserved by MedPath